Firstly we discovered a significant relationship between IDH1/2 mutations status and MDS prognosis in the Chinese population, IDH mutations predicted more adverse OS for patients with MDS (P = 0.007). This evidence concerns the gene IDH2 and myelodysplastic syndrome.